Clinical Immunology and Allergy: A new path in Immunotherapy
Journal of Clinical Immunology and Allergy is a world class open access journal intended to publish the cutting-edge research in the field of Immunology and Allergy.
Journal of Clinical Immunology and Allergy endeavours to publish both basic, fundamental and advanced developmental research in allergy, respiratory diseases, diagnosis, preventive treatment methodologies, New drug development, combinatorial anti allergen, anti-inflammatory and antibacterial drug therapy and research.
Allergy is caused by the series reactions of hypersensitivity of immune system. It can be defined as a damaging immune response by the body to a substance generally called as an allergen. A substance that causes an allergic reaction is called an "allergen".
Allergic diseases include hay fever, food allergies, atopic dermatitis, allergic asthma, and anaphylaxis.
The climate change also poses a range of threats to human health. An increase of more than 2 degrees Celsius in average temperature would result in negative health impacts in all geographical regions. Impacts can be indirect to human health, such as effects on agriculture, disease appearance as well as to economics or even social life.
Journal accepts original manuscripts in the form of research articles, review articles, Clinical reviews, commentaries, case reports, perspectives and short communications encompassing all aspects of Clinical Immunology and Allergy for publication in open access platform.
All the manuscript published by Clinical Immunology and Allergy are available freely online immediately after publication without any subscription charges or registration.
You can Submit your manuscript at http://www.imedpub.com/submissions/insights-allergy-asthma-bronchitis.html or as an attachment to this
How we work:
• After submission, an acknowledgement with manuscript number is sent to the corresponding author within 7 working days.
• A 21-day window time frame is allotted for peer-review process wherein multiple experts are contacted.
• Author proof is generated within 7 working days after the acceptance decision.
Benefits on Publication:
Open Access: Permanent free access to your article upon publication ensures extensive global reach and readership.
Easy Article Sharing:
Our open access enables you to share your article directly with colleagues through email and on social media via a single link, permitting third party reuse with appropriate citation in addition to the retention of content copyright by the author.
Through promotion in a targeted global email announcement or press release, your article will be seen by thousands of the top-most thought-leaders in your field.
In a world of black & white journal articles, high-quality full-color images make your article stand out from the crowd and tell a complete story, increasing readers and citations.
Social Media Exposure:
Extended reach for your article through links on Twitter accounts provides maximum visibility worldwide.
Distribute your work to colleagues and at conferences as we provide hard copy color reprints of your article on order.
Clinical Immunology and Allergy